Literature DB >> 16049916

Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.

Yasuhiro Nakashima1, Hiroyuki Tagawa, Ritsuro Suzuki, Sivasundaram Karnan, Kennosuke Karube, Koichi Ohshima, Koichiro Muta, Hajime Nawata, Yasuo Morishima, Shigeo Nakamura, Masao Seto.   

Abstract

Natural killer (NK) cell lymphomas/leukemias are highly aggressive lymphoid malignancies, but little is known about their genomic alterations, and thus there is an urgent need for identification and analysis of NK cell lymphomas/leukemias. Recently, we developed our own array-based comparative genomic hybridization (array CGH) with an average resolution of 1.3 Mb. We performed an array CGH analysis for 27 NK-cell lymphoma/leukemia cases that were classified into two disease groups based on the World Health Organization Classification (10 aggressive NK-cell leukemia cases and 17 extranodal NK/T-cell [NK/T] lymphomas, nasal type). We identified the differences in the genomic alteration patterns of the two groups. The recurrent regions characteristic of the aggressive NK-cell leukemia group compared with those of the extranodal NK/T lymphoma, nasal-type group, were gain of 1q and loss of 7p15.1-p22.3 and 17p13.1. In particular, gain of 1q23.1-24.2 (P = 0.041) and 1q31.3-q44 (P = 0.003-0.047), and loss of 7p15.1-p22.3 (P = 0.012-0.041) and 17p13.1 (P = 0.012) occurred significantly more frequently in the former than in the latter group. Recurrent regions characteristic of the extranodal NK/T lymphoma, nasal-type group, compared with those of the other group were gain of 2q, and loss of 6q16.1-q27, 11q22.3-q23.3, 5p14.1-p14.3, 5q34-q35.3, 1p36.23-p36.33, 2p16.1-p16.3, 4q12, and 4q31.3-q32.1. Our results can be expected to provide further insights into the genetic basis of lymphomagenesis and the clinicopathologic features of NK-cell lymphomas/leukemias. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049916     DOI: 10.1002/gcc.20245

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  50 in total

1.  Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow.

Authors:  Sherif A Rezk; Qin Huang
Journal:  Int J Clin Exp Pathol       Date:  2011-10-10

2.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.

Authors:  Christine L O'Keefe; Ramon Tiu; Lukasz P Gondek; Jennifer Powers; Karl S Theil; Matt Kalaycio; Alan Lichtin; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

Review 4.  Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

Authors:  Bradley M Haverkos; Carrie Coleman; Alejandro A Gru; Zenggang Pan; Jonathan Brammer; Rosemary Rochford; Anjali Mishra; Christopher C Oakes; Robert A Baiocchi; Aharon G Freud; Pierluigi Porcu
Journal:  Discov Med       Date:  2017-03       Impact factor: 2.970

5.  Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.

Authors:  Fumihiro Ishida; Young Hyeh Ko; Won Seog Kim; Junji Suzumiya; Yasushi Isobe; Kazuo Oshimi; Shigeo Nakamura; Ritsuro Suzuki
Journal:  Cancer Sci       Date:  2012-03-23       Impact factor: 6.716

6.  Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.

Authors:  Liang Huang; Dan Liu; Na Wang; Shaoping Ling; Yuting Tang; Jun Wu; Lingtong Hao; Hui Luo; Xuelian Hu; Lingshuang Sheng; Lijun Zhu; Di Wang; Yi Luo; Zhen Shang; Min Xiao; Xia Mao; Kuangguo Zhou; Lihua Cao; Lili Dong; Xinchang Zheng; Pinpin Sui; Jianlin He; Shanlan Mo; Jin Yan; Qilin Ao; Lugui Qiu; Hongsheng Zhou; Qifa Liu; Hongyu Zhang; Jianyong Li; Jie Jin; Li Fu; Weili Zhao; Jieping Chen; Xin Du; Guoliang Qing; Hudan Liu; Xin Liu; Gang Huang; Ding Ma; Jianfeng Zhou; Qian-Fei Wang
Journal:  Cell Res       Date:  2017-11-17       Impact factor: 25.617

7.  Defining ploidy-specific thresholds in array comparative genomic hybridization to improve the sensitivity of detection of single copy alterations in cell lines.

Authors:  Grace Ng; Jingxiang Huang; Ian Roberts; Nicholas Coleman
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

8.  EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.

Authors:  Alina Nicolae; Karthik A Ganapathi; Trinh Hoc-Tran Pham; Liqiang Xi; Carlos A Torres-Cabala; Nahid M Nanaji; Hongbin D Zha; Zhen Fan; Sybil Irwin; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 9.  NK/T Cell Lymphoma: Updates in Therapy.

Authors:  Ritsuro Suzuki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

10.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yenlin Huang; Aurélien de Reyniès; Laurence de Leval; Bouchra Ghazi; Nadine Martin-Garcia; Marion Travert; Jacques Bosq; Josette Brière; Barbara Petit; Emilie Thomas; Paul Coppo; Teresa Marafioti; Jean-François Emile; Marie-Hélène Delfau-Larue; Christian Schmitt; Philippe Gaulard
Journal:  Blood       Date:  2009-11-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.